ischemic cardiomyopathy
Conditions
Interventions
Control group:Conventional Western medicine treatment involves the use of diuretics, beta-blockers, ARNI, anticoagulants and other drugs as recommended by the guidelines
Treatment group:Based on the medication of the control group, use Shenqi Yangxin Decoction
Sponsors
Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 89 Years
Inclusion criteria
Inclusion criteria: (1) It meets the diagnostic criteria of ICM for Western medicine and the diagnostic criteria for Qi and Yin deficiency and blood stasis syndrome in traditional Chinese medicine.(2) Be over 18 years old;(3) Voluntarily participate in this research and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Suffering from severe liver and kidney dysfunction, malignant tumors, mental disorders, etc. (2) Women who are preparing for pregnancy or are pregnant or breastfeeding; (3) Those who have been bedridden for a long time and have unstable vital signs; (4) Those who are known to be allergic to the drug components used in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM syndrome score;Echocardiography related indicators;Macrophages; | — |
Secondary
| Measure | Time frame |
|---|---|
| Minnesota Heart Failure quality of Life score;N-terminal pro-B-type natriuretic peptide;6-minute walk test;New York Heart Association functional class;serum H2S;monocytes;inflammatory factor;sST2;blood routine examination;hepatic and renal function;electrolyte; | — |
Countries
China
Contacts
Public ContactZhang Zhuojun
Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine
Outcome results
None listed